BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15842212)

  • 1. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
    D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
    Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
    Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
    Toprak A; Erenus M; Ilhan AH; Haklar G; Fak AS; Oktay A
    Climacteric; 2005 Sep; 8(3):279-86. PubMed ID: 16390760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
    Rachoń D; Suchecka-Rachoń K; Hak Ł; Myśliwska J
    Menopause; 2006; 13(5):840-5. PubMed ID: 16894332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
    Bingol B; Gunenc Z; Yilmaz M; Biri A; Tiras B; Güner H
    Arch Gynecol Obstet; 2010 May; 281(5):857-64. PubMed ID: 19593578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.
    Vitale C; Gebara O; Mercuro G; Wajngarten M; Silvestri A; Rossini P; Ramires JA; Fini M; Rosano GM
    Maturitas; 2005 Apr; 50(4):239-46. PubMed ID: 15780522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of hormone replacement therapy on homocysteine and echocardiography in postmenopausal women].
    Hui Y; Wu Y; Xiao L; Tang Z; Wu Y; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):598-600. PubMed ID: 12487933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
    Pirimoglu ZM; Aygun E; Dansuk R; Kucukercan I; Unal O; Turan C
    Gynecol Endocrinol; 2005 Sep; 21(3):185-8. PubMed ID: 16335913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
    Eilertsen AL; Høibraaten E; Os I; Andersen TO; Sandvik L; Sandset PM
    Maturitas; 2005 Oct; 52(2):111-8. PubMed ID: 16186073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral or transdermal hormone replacement therapy on homocysteine levels: a randomized clinical trial.
    Bruschi F; Dal Pino D; Fiore V; Parazzini F; Di Pace R; Cesana BM; Melotti D; Crosignani PG
    Maturitas; 2004 May; 48(1):33-8. PubMed ID: 15223106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study.
    Atteritano M; Pernice F; Mazzaferro S; Mantuano S; Frisina A; D'Anna R; Cannata ML; Bitto A; Squadrito F; Frisina N; Buemi M
    Eur J Pharmacol; 2008 Jul; 589(1-3):22-6. PubMed ID: 18541232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
    Kurtay G; Ozmen B
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):206-11. PubMed ID: 16814449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G; Ozmen B; Erguder I
    Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women].
    Alfonso Cano C; Vez García MD; García Urruticoechea P; Tornel Osorio PL; Canteras Jordana M; Abellán Alemán J
    An Med Interna; 2003 Feb; 20(2):70-4. PubMed ID: 12703158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
    Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
    Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study.
    Marini H; Bitto A; Altavilla D; Burnett BP; Polito F; Di Stefano V; Minutoli L; Atteritano M; Levy RM; Frisina N; Mazzaferro S; Frisina A; D'Anna R; Cancellieri F; Cannata ML; Corrado F; Lubrano C; Marini R; Adamo EB; Squadrito F
    Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):332-40. PubMed ID: 19631515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
    Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
    Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.